DXB vs RNV

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

40LOW

RNV

RENERVE FPO [RNV]

38LOW

Score Breakdown

DXB RNV
Technical
45
61
Catalyst
48
53
Sentiment
50
50
Fundamental
82
54
Momentum
36
48
Risk Gate
50
40

Key Metrics

DXB Metric RNV
$141.1MMarket Cap$13.8M
3.2MAvg Volume (20d)66K
N/AShort InterestN/A
$0.66552-Week High$0.220
$0.15852-Week Low$0.069
+2.1%Daily Change+0.0%
$0.240Reference Price$0.080
-594.5%ROE-74.9%
-219.9%Profit MarginN/A

Active Signals

DXB Signals

●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-29
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (15% of range)

RNV Signals

●MACD momentum is picking up steam
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Strong revenue growth (+60%)
●Near 52-week low (7% of range)
●Micro-cap ($5-20M) - high risk

Ask Scout AI to compare DXB and RNV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

DXB vs SHG →DXB vs VHL →EBO vs EMV →EBO vs HLS →EBO vs IMC →
DXB Full Analysis → RNV Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).